Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
969 | 2840 | 47.9 | 85% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
668 | 12550 | NASOPHARYNGEAL CARCINOMA//EPSTEIN BARR VIRUS//EBV |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | LMP1 | Author keyword | 80 | 56% | 3% | 98 |
2 | LATENT MEMBRANE PROTEIN 1 | Author keyword | 78 | 57% | 3% | 93 |
3 | EBV | Author keyword | 33 | 15% | 7% | 204 |
4 | EBNA1 | Author keyword | 31 | 52% | 2% | 43 |
5 | PROGRAM VIRAL ONCOGENESIS TUMOR IMMUNOL | Address | 31 | 92% | 0% | 12 |
6 | LMP 1 | Author keyword | 23 | 47% | 1% | 37 |
7 | ORIP | Author keyword | 23 | 70% | 1% | 19 |
8 | BARF1 | Author keyword | 21 | 85% | 0% | 11 |
9 | EBNA2 | Author keyword | 20 | 66% | 1% | 19 |
10 | EBNA 1 | Author keyword | 18 | 49% | 1% | 27 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | LMP1 | 80 | 56% | 3% | 98 | Search LMP1 | Search LMP1 |
2 | LATENT MEMBRANE PROTEIN 1 | 78 | 57% | 3% | 93 | Search LATENT+MEMBRANE+PROTEIN+1 | Search LATENT+MEMBRANE+PROTEIN+1 |
3 | EBV | 33 | 15% | 7% | 204 | Search EBV | Search EBV |
4 | EBNA1 | 31 | 52% | 2% | 43 | Search EBNA1 | Search EBNA1 |
5 | LMP 1 | 23 | 47% | 1% | 37 | Search LMP+1 | Search LMP+1 |
6 | ORIP | 23 | 70% | 1% | 19 | Search ORIP | Search ORIP |
7 | BARF1 | 21 | 85% | 0% | 11 | Search BARF1 | Search BARF1 |
8 | EBNA2 | 20 | 66% | 1% | 19 | Search EBNA2 | Search EBNA2 |
9 | EBNA 1 | 18 | 49% | 1% | 27 | Search EBNA+1 | Search EBNA+1 |
10 | EBNA 2 | 15 | 77% | 0% | 10 | Search EBNA+2 | Search EBNA+2 |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | LYMPHOCYTE GROWTH TRANSFORMATION | 353 | 83% | 7% | 198 |
2 | LATENT MEMBRANE PROTEIN | 205 | 51% | 10% | 285 |
3 | NUCLEAR ANTIGEN 2 | 171 | 68% | 5% | 151 |
4 | MEMBRANE PROTEIN 1 | 164 | 50% | 8% | 238 |
5 | SIGNAL BINDING PROTEIN | 148 | 76% | 4% | 104 |
6 | BNLF 1 GENE | 146 | 96% | 2% | 46 |
7 | LMP1 | 141 | 67% | 5% | 128 |
8 | LATENT MEMBRANE PROTEIN 1 | 139 | 47% | 8% | 217 |
9 | STABLE REPLICATION | 128 | 66% | 4% | 120 |
10 | NUCLEAR PROTEIN 2 ACIDIC DOMAIN | 118 | 95% | 1% | 39 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Epstein-Barr virus: 40 years on | 2004 | 816 | 133 | 58% |
The role of the EBV-encoded latent membrane proteins LMP1 and LMP2 in the pathogenesis of nasopharyngeal carcinoma (NPC) | 2012 | 59 | 150 | 83% |
Epstein-Barr virus in the pathogenesis of NPC | 2002 | 260 | 87 | 80% |
The Epstein-Barr virus and the pathogenesis of lymphoma | 2015 | 6 | 145 | 35% |
Mechanisms of disease - Persistence of the Epstein-Barr virus and the origins of associated lymphomas | 2004 | 407 | 51 | 53% |
Epstein-Barr virus and oncogenesis: from latent genes to tumours | 2003 | 247 | 133 | 54% |
The extent of genetic diversity of Epstein-Barr virus and its geographic and disease patterns: A need for reappraisal | 2009 | 57 | 139 | 82% |
The role of Epstein-Barr virus in epithelial malignancies | 2015 | 2 | 98 | 51% |
B cells under influence: Transformation of B cells by Epstein-Barr virus | 2003 | 244 | 87 | 44% |
The plasmid replicon of Epstein-Barr virus: Mechanistic insights into efficient, licensed, extrachromosomal replication in human cells | 2007 | 58 | 85 | 80% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | PROGRAM VIRAL ONCOGENESIS TUMOR IMMUNOL | 31 | 92% | 0.4% | 12 |
2 | GENE VECTORS | 15 | 32% | 1.3% | 38 |
3 | TUMOR VIROL | 12 | 17% | 2.2% | 62 |
4 | HERPESVIRUS | 9 | 64% | 0.3% | 9 |
5 | VIRUS VECTOR DEV | 8 | 75% | 0.2% | 6 |
6 | PARASITOL CHAGAS DIS | 6 | 80% | 0.1% | 4 |
7 | CLIN MOL BIOL TUMOR GENET | 6 | 19% | 1.0% | 28 |
8 | KLIN MOL BIOL TUMORGENET | 5 | 31% | 0.5% | 14 |
9 | LINK S | 4 | 75% | 0.1% | 3 |
10 | BEADLE E141 | 3 | 57% | 0.1% | 4 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000270547 | BZLF1//BRLF1//VIRAL MOL TUMOR DIAGNOST UNIT |
2 | 0.0000250495 | AUSTRALIAN VACCINE DEV TUMOUR IMMUNOL//EPSTEIN BARR VIRUS NUCLEAR ANTIGEN 1//JOINT ONCOL PROGRAM |
3 | 0.0000177846 | LYMPHOEPITHELIOMA LIKE CARCINOMA//LYMPHOEPITHELIOMA//LYMPHOEPITHELIAL CARCINOMA |
4 | 0.0000123624 | NGX6//BRD7 GENE//NGX6 GENE |
5 | 0.0000081677 | SLAM ASSOCIATED PROTEIN SAP//ANTI CMV ANTIBODIES//VARICELLA ARTHRITIS |
6 | 0.0000078630 | O I//VIRAL MICRORNAS//VIRAL MIRNA |
7 | 0.0000074814 | POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER//PTLD//POST TRANSPLANT LYMPHOPROLIFERATIVE DISEASE |
8 | 0.0000071647 | HERPESVIRUS SAIMIRI//KLIN MOL VIROL//STPC |
9 | 0.0000069892 | HERPES B VIRUS//CERCOPITHECINE HERPESVIRUS 1//B VIRUS |
10 | 0.0000069378 | HODGKINS DISEASE//NODULAR LYMPHOCYTE PREDOMINANT HODGKIN LYMPHOMA//HODGKIN LYMPHOMA |